Balyasny Asset Management
TARO

Balyasny Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Balyasny Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,444
Closed -$569K – 3247
2024
Q1 		$569K Buy
+13,444
New +$566K ﹤0.01% 2004
2023
Q2 		– Sell
-14,056
Closed -$342K – 2983
2023
Q1 		$342K Buy
+14,056
New +$410K ﹤0.01% 2058
2018
Q1 		– Sell
-2,072
Closed -$217K – 2396
2017
Q4 		$217K Buy
+2,072
New +$228K ﹤0.01% 1874

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $1.65B AUM 25.75% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Balyasny Asset Management's TARO Position: Q2 2024 in Review

Balyasny Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 13,444 shares — an estimated $569K sold.

Balyasny Asset Management first reported a position in TARO in Q4 2017 and held it in 3 quarters. The position peaked at $569K in Q1 2024. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Balyasny Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 13,444 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $569K.
  • Balyasny Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 3 quarters.
  • Balyasny Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $569K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Balyasny Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.